Successive Diabetic Macroangiopathy for Cerebral, Cardiac and Peripheral Vascular Operation

Bando H, Ogawa H, Nagahiro S, Kobayashi, H, Nakanishi M and Watanabe O

Published on: 2023-05-07

Abstract

Current case is 57-year-old male treated by 12-year insulin with type 2 Diabetes (T2D) for 22 years. HbA1c was stable for 6.3-6.8% until 2021. After that, he developed several events of cerebral vascular accident (CVA), ischemic heart disease (IHD) and peripheral artery disease (PAD). He received superficial temporal artery (STA)-middle cerebral artery (MCA) bypass for CVA, percutaneous coronary intervention (PCI) by drug-eluting stent placement for IHD, and treatment of SMART stent at superficial femoral artery (SFA) for PAD. Consequently, he has suffered from macroangiopathy and microangiopathy as neuropathy, retinopathy and nephropathy. Serum creatinine increased 1.03 to 1.67mg/dL for 18 months.